Volume 6,Issue 3
Bee venom (BV) is the secretion that is produced by a needle device for protecting the bee from an enemy. However, BV has been applied in folk medicine for various diseases because it has many enzymes which contain anti-inflammatory or anti-cancer action. Above all, phospholipase A2 (PLA2) is a hydrolytic enzyme that cleaves membrane phospholipids and occupies up to 12% of bee venom. PLA2 has been analyzed in great detail. This minireview sets out the latest scientific evidence concerning the therapeutic effects of PLA2 in the context of diseases and provides a detailed description of the mechanisms.
1. Yamamoto K, Murakami M. Phospholipase A2. Biochemistry, 2011(83): 449–461.
2. Perez-Riverol A, Lasa AM, Dos Santos-Pinto JRA, et al. Insect Venom Phospholipases A1 and A2: Roles in the Envenoming Process and Allergy. Insect Biochem Mol Biol, 2019(105): 10–24.
3. Hossen MS, Shapla UM, Gan SH, et al. Impact of Bee Venom Enzymes on Diseases and Immune Responses. Molecules, 2016(22): E25.
4. Chung ES, Lee G, Lee C, et al. Bee Venom Phospholipase A2, a Novel Foxp3+Regulatory T Cell Inducer, Protects Dopaminergic Neurons by Modulating Neuroinflammatory Responses in a Mouse Model of Parkinson’s Disease. J Immunol, 2015(195): 4853–4860.
5. Almunia C, Bretaudeau M, Held G, et al. Bee Venom Phospholipase A2, a Good “Chauffeur” for Delivering Tumor Antigen to the MHC Ⅰ and MHC Ⅱ Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1. PLoS One, 2013(8): e67645.
6. Moreira LA, Ito J, Ghosh A, et al. Bee Venom Phospholipase Inhibits Malaria Parasite Development in Transgenic Mosquitoes. J Biol Chem, 2002(277): 40839–40843.